Browse by title
Marta Díaz Pozo
This chapter provides a general introduction to the book. The chapter reviews the historical development of the biotechnology industry and the difficulties in applying conventional European patent law rules to genetic inventions. In particular, the chapter presents the concerns regarding the lack of industrial application of patent claims over isolated human DNA sequences and the importance of this requirement in the patenting of inventions concerning human genes.
Mary Guy and Wolf Sauter
Mary Guy and Wolf Sauter lay out the scope and historical development of EU Health Law and Policy. The analysis reveals three broad periods of development: up to 1992, when focusing on the four freedoms (goods, services, workers and capital) led to incremental legislative action on health; 1992–2007, from the adoption of an explicit health competence at an integrationist high-point in the early 1990s to the Lisbon Treaty in 2007; and 2007 onwards, where integration continues despite political malaise and an economic downturn. Guy and Sauter note that EU Health Law and Policy has moved beyond a ‘patchwork’ or ‘interface’ approach to a more coherent legal and policy domain, and also a subject for academic study in its own right.